Lipocine (LPCN) Payables (2016 - 2025)
Historic Payables for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to $861452.0.
- Lipocine's Payables rose 20189.63% to $861452.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $861452.0, marking a year-over-year increase of 20189.63%. This contributed to the annual value of $271696.0 for FY2024, which is 8053.72% down from last year.
- Latest data reveals that Lipocine reported Payables of $861452.0 as of Q3 2025, which was up 20189.63% from $442994.0 recorded in Q2 2025.
- In the past 5 years, Lipocine's Payables registered a high of $1.4 million during Q4 2023, and its lowest value of $271696.0 during Q4 2024.
- Its 5-year average for Payables is $691975.2, with a median of $630456.0 in 2022.
- As far as peak fluctuations go, Lipocine's Payables plummeted by 8053.72% in 2024, and later soared by 20189.63% in 2025.
- Quarter analysis of 5 years shows Lipocine's Payables stood at $1.3 million in 2021, then tumbled by 53.43% to $600388.0 in 2022, then skyrocketed by 132.51% to $1.4 million in 2023, then crashed by 80.54% to $271696.0 in 2024, then surged by 217.06% to $861452.0 in 2025.
- Its last three reported values are $861452.0 in Q3 2025, $442994.0 for Q2 2025, and $360239.0 during Q1 2025.